SlideShare a Scribd company logo
Visual
Assessment
Guide
Canadian Blood Services
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES T05 021 JANUARY 2009 i
Table of Contents
Introduction	 1
How to Use	 3
Quick Reference Guide	
Table 1 - Summary of Visual Appearance	 4
Table 2 - Summary of Acceptability Criteria 	 5
Red Cell Components	 6
Platelet Components	 12
Plasma Components	 18
Cryoprecipitate Components	 25
References	 26
Acknowledgement	 27
ISBN 978-1-926581-14-9
© 2009, Canadian Blood Services
T05 021 JANUARY 2009CANADIAN BLOOD SERVICES 1
INTRODUCTION
Typical Platelet
(platelet pool from 4 donors
using the buffy coat method)
Introduction
Whole blood donations are collected into a closed bag system
that permits aseptic separation into red cells, platelets,
plasma and cryoprecipitate. Currently, there are three whole
blood processing systems used by the Canadian Blood
Services: Buffy Coat (BC) method, Platelet Rich Plasma
(PRP) method and Whole Blood (WB) filtration. Platelet and
plasma components are also collected by apheresis. Blood
components manufactured by Canadian Blood Services are
done so under strict manufacturing protocols.
CANADIAN BLOOD SERVICES
INTRODUCTION
2
This guide has been produced for use by both Canadian
Blood Services and hospital personnel.
The acceptability of a blood component for release from
Canadian Blood Services is determined by Canadian Blood
Services protocols and procedures.
The acceptability of a blood component for transfusion
will be determined by local hospital policy and procedures
under the direction of the Transfusion Services Medical
Director (ref CSA-Z902-04 4.3.6.1).
Typical Plasma prepared from whole blood
T05 021 JANUARY 2009
T05 021 JANUARY 2009CANADIAN BLOOD SERVICES
HOWTOUSE
This guide is divided into four sections covering the
four blood components. Each section begins with a
brief explanation of the component, a description of the
variations in appearance for that component and criteria for
acceptability.
Inspection of the blood products should take place in a
well-lit area. Coloured products have been photographed
against a white background, whereas light-coloured
(white) products have been photographed against a dark
background to obtain a better viewing contrast.
Visual Assessments Guides printed by the Canadian Blood
Services are laminated to increase their durability; however
the quality of the photographs may decrease over time.
How to Use
This Visual
Assessment Guide
Prolonged exposure to sunlight or fluorescent lighting may
cause fading and to maintain the quality of the photographs,
please keep the guide closed when not in use.
This guide is available on www.transfusionmedicine.ca
and if it is printed locally or viewed on-line the pictures may
not be color-true.
Table 1 is a quick guide for conditions that affect the visual
appearance of components. Not all conditions affect all
components.
Table 2 is a summary of the acceptability criteria.
Note: Storage containers may differ in appearance depending
on bag vendor. Labels may or may not appear on the back of
products and label formats and locations may be different.
3
T05 021 JANUARY 2009CANADIAN BLOOD SERVICES
QUICKREFERENCEGUIDE
Affected Component
Condition Red cells Platelets Plasma Cryoprecipitate
Hemolysis
• Loss of intact red cells results in lower hematocrit and a
brighter cherry red color.
• Free hemoglobin imparts a light pink tinge to a dark red
almost purple color to the supernatant.
• Occurs as part of normal aging process
n/a
• Red cells present in plasma will
hemolyze during the freeze/thaw
process and will impart a pink to
red tinge depending on number
of red cells involved
• Red cells present in plasma will
hemolyze during the freeze/thaw
process and will impart a pink to
red tinge depending on number
of red cells involved
Red cell
contamination
n/a
• Varies from a light pink / salmon
color tinge to a marked red
discoloration
• Varies from a light pink /
salmon color tinge to a marked
red discoloration
• Varies from a light pink /
salmon color tinge to a marked
red discoloration
Lipemia
• A lighter shade of red and an increased opacity of the
unit similar to a ‘strawberry milkshake’
• Increased opacity
• ‘Milky’ white appearance
• Increased opacity
• ‘Milky’ white appearance
• Increased opacity
• ‘Milky’ white appearance
Icterus n/a • Bright yellow to brown • Bright yellow to brown • Bright yellow to brown
Bacterial
contamination
• A dark purple to black discoloration in red cells
• Excessive and unusual air bubbles
• Clots and fibrin strands
• Increased opacity
• When assosiated with hemolysis, a pink to red discoloration
may be seen in supernatant.
• Excessive and unusual air
bubbles
• Clots and fibrin strands
• Increased opacity
• Grey discoloration
• Excessive and unusual air
bubbles
• Clots and fibrin strands
• Increased opacity
• Excessive and unusual air
bubbles
• Clots and fibrin strands
• Increased opacity
Particulate
matter
• Clots appear as small to large dark red or purple masses
that do not dissipate with gentle manipulation in red cells.
• Cellular aggregates appear as white and opaque masses
that do not dissipate with gentle manipulation.
• White particulate matter varies from flattened specks to a
greasy film and may dissipate with a change in
temperature
• Cold agglutinins form large red blood cell masses that do
not dissipate with gentle manipulation.
• Clots and fibrin strands result from
the activation of the clotting
process and may appear as
white/opaque masses or whitish
thread like strands that do not
dissipate with gentle manipulation
• Cellular aggregates may appear
as white and opaque masses
that do not dissipate with gentle
manipulation.
• Particulate matter may vary
considerably in size.
• Clots and fibrin strands result from
the activation of the clotting
process and may appears as
white/opaque masses or whitish
thread like strands that do not
dissipate with gentle manipulation
• Cellular aggregates may appear
as white and opaque masses
that do not dissipate with gentle
manipulation.
• Particulate matter may vary
considerably in size.
• Clots and fibrin strands result from
the activation of the clotting
process and may appears as
white/opaque masses or whitish
thread like strands that do not
dissipate with gentle manipulation
• Cellular aggregates may appear
as white and opaque masses
that do not dissipate with gentle
manipulation.
• Particulate matter may vary
considerably in size.
Discoloration • See hemolysis, lipemia, bacterial contamination
• Pink, red, bright orange / yellow,
bright green, or brown
• Pink, red, bright orange / yellow,
bright green, or brown
• Pink, red, bright orange / yellow,
bright green, or brown
Quick Reference Guide
Table 1. Visual appearance of blood components
n/a=Not applicable
4
T05 021 JANUARY 2009CANADIAN BLOOD SERVICES 5
QUICKREFERENCEGUIDE
Affected Component
Condition Red cells Platelets Plasma Cryoprecipitate
Hemolysis
• Some degree of hemolysis is acceptable
and expected. The CSA standard will
define acceptable levels of hemolysis as
< 0.8% at expiry.
n/a
• Some degree of hemolysis is possible
depending on the number of red cells
in the plasma.
• Some degree of hemolysis is possible
depending on the number of red cells
in the plasma.
Red cell
contamination
n/a
• Currently there are no standards of
acceptability of red cell contamination for
platelet units. However, the AABB standards
recommend compatibility testing when an
apheresis platelet contains more than 2ml of
red cells (ref AABB standard 24th ed 5.14.5).
• Currently, there are no standards of
acceptability for red cell contamination
of plasma units.
• Currently, there are no standards
of acceptability for red cell
contamination of plasma units.
Lipemia
• Blood components with lipemia are
acceptable for transfusion.
• Blood components with lipemia are
acceptable for transfusion.
• Blood components with lipemia are
acceptable for transfusion.
• Blood components with lipemia are
acceptable for transfusion.
Icterus
• Blood components with icterus are
acceptable for transfusion.
• Blood components with icterus are
acceptable for transfusion.
• Blood components with icterus are
acceptable for transfusion.
• Blood components with icterus are
acceptable for transfusion.
Bacterial
contamination
• Bacterially contaminated blood
components are not acceptable for
transfusion
• Canadian Blood Services routinely tests
platelets derived from whole blood or
apheresis for bacterial contamination.
Bacterially contaminated blood components
are not acceptable for transfusion.
• Bacterially contaminated blood
components are not acceptable for
transfusion
• Bacterially contaminated blood
components are not acceptable for
transfusion
Particulate
matter
• Clots and fibrin - Blood components
containing clots and / or fibrin strands
should not be transfused.
• Cellular aggregates - Blood components
containing cellular aggregates should not
be transfused.
• White Particulate Matter (WPM). Blood
components containing WPM are
acceptable for transfusion. WPM may
dissipate with a change in temperature.
• Cold agglutinins - Blood components
containing cold agglutinin masses should
not be transfused.
• Clots and fibrin Strands - Blood components
containing clots and/or fibrin strands should
not be transfused.
• Cellular aggregates- Blood components
containing cellular aggregates should not be
transfused.
• Clots and fibrin - Blood components
containing clots and / or fibrin strands
should not be transfused.
• Cellular Aggregates - Blood
components containing cellular
aggregates should not be transfused.
• White Particulate Matter (WPM) - WPM
may be seen in thawed plasma that
has been stored in the fridge. Blood
components containing WPM are
acceptable for transfusion
• Clots and fibrin - Blood components
containing clots and / or fibrin
strands should not be transfused.
• Cellular Aggregates - Blood
components containing cellular
aggregates should not be transfused.
• White Particulate Matter (WPM) -
WPM may be seen in thawed plasma
that has been stored in the fridge.
Blood components containing WPM
are acceptable for transfusion
Discoloration
• See hemolysis, lipemia, bacterial
contamination
• Discoloration due to icterus (yellow),
oral contraceptives (green), vitamin A or
large quantities of carrots (orange) are all
acceptable for transfusion.
• Discoloration due to icterus (yellow),
oral contraceptives (green), vitamin A
or large quantities of carrots (orange)
are all acceptable for transfusion.
• Discoloration due to icterus (yellow),
oral contraceptives (green), vitamin A
or large quantities of carrots (orange)
are all acceptable for transfusion.
Quick Reference Guide
Table 2. Acceptability criteria of blood components
n/a=Not applicable
CANADIAN BLOOD SERVICES
REDCELLCOMPONENTS
Typical Red Blood Cells
prepared from whole blood
Red Cell
Components
Red Cell Units
Red cell units are an even suspension
of red cells in a small amount of
residual plasma and additive solution.
The visual appearance of segments
should not be used to assess a red
cell unit as they may not reflect the
content of the bag.6
Units should
be allowed to settle to permit an
assessment of the supernatant. There
is a normal variation in the shade of
red seen in red cell units that may
reflect a difference in the hematocrit
of the donor (i.e. a higher hematocrit
will result in a darker red).
6T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
REDCELLCOMPONENTS
Appearance of Red Cell Units
There are several conditions that may change the
appearance of the red cell unit:
Hemolysis
•	 Visual appearance
–	 Of particular note, hemolysis caused by bacterial
contamination may result in a dark purple to black
discoloration (see ‘Bacterial Contamination’).
–	 Free hemoglobin within the supernatant of red
cells will cause a discoloration that will vary from
a light pink tinge to a dark red almost purple
color, depending on the extent of hemolysis (i.e. a
higher degree of hemolysis will result in a darker
discoloration).
•	 Hemolysis is the break down of red cells and the
subsequent release of hemoglobin, the pigmented
protein in red cells. Hemolysis of stored red cells is
a normal process and increases with storage times.
Some degree of hemolysis is acceptable and expected.
The CSA standard will define acceptable levels of
hemolysis as < 0.8% at expiry.
7
•	 Visual assessment of supernatant color is the only
non-destructive means to estimate hemolysis in a red
cell unit. It is very subjective and it is difficult to define
a “cut-off” color for determining a unit’s acceptability.
The color of the supernatant varies according to the
volume of the supernatant and the hematocrit and
hemoglobin levels in the red cell unit.	
	 The presence of red cells in the supernatant may be
mistaken for hemolysis. If hemolysis is suspected, it
may be worthwhile to allow the unit to settle for 24
hours or more to minimize red cell contamination of the
supernatant prior to inspection for hemolysis.
•	 There are numerous causes of hemolysis. A few
examples related to the manufacturing process and
subsequent handling of red cell units are:
–	 Temperature extremes
–	 Excessive centrifugation
–	 Tubing stripping
–	 Tubing heat sealers
–	 Sheer force during manufacturing eg. kinked
tubing, improperly broken cannula
–	 Bacterial contamination
–	 Mishandling
–	 Incompatible solutions
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
REDCELLCOMPONENTS
8
Supernatant of RBC
Percent Hemolysis = 0.11 %
Photographs were taken after allowing the
RBC to settle for 4 days to permit an evident
visualization of the supernatant. This assessment
may be performed earlier or later.
Supernatant of RBC
Percent Hemolysis = 0.36 %
Supernatant of RBC showing
higher levels of hemolysis
Percent Hemolysis = 1.14 %
T05 021 JANUARY 2009
The CSA standard will define acceptable levels of hemolysis as < 0.8% at expiry.
CANADIAN BLOOD SERVICES
REDCELLCOMPONENTS
Lipemia
•	 Visual appearance
–	 The appearance of a lipemic red
cell unit has been compared to a
‘strawberry milkshake’.
•	 Lipemia is the presence of lipid particles in the blood.
The presence of lipemia is acceptable for transfusion.
When excessive lipemia interferes with testing all
components are discarded at Canadian Blood Services.
•	 Causes of lipemia in a red cell unit are donor related and
may be related to:
–	 Fatty meals before blood donation
–	 Chronic conditions such as hypercholesterolemia
Bacterial contamination
•	 Visual appearance – There are usually no visible changes
to the component, but occasionally it may be possible to
detect the following:
–	 Growing bacteria within a red cell unit may
consume the oxygen and cause a dark purple to
black discoloration in red cells.
–	 The presence of bacteria may produce gas
resulting in excessive and unusual air bubbles.
Lipemic RBC Unit
No picture available
at this time
9
–	 The presence of bacteria may activate
clotting resulting in clots and fibrin
strands.
–	 Increased opacity
–	 Because bacterial contamination
can cause hemolysis, a pink to red
discoloration may be seen in the
supernatant.
•	 Bacterial contamination is the presence of bacteria in the
blood. Blood should be free of bacteria. Blood donations
are collected and then processed in a closed system to
maintain aseptic conditions.
	 Bacterially contaminated blood components are not
acceptable for transfusion.
•	 Bacterial contamination may be related to the donor or
subsequent manufacturing processes.
–	 Donor with asymptomatic bacteremia (i.e. bacteria
in blood)
–	 Inadequate cleansing of skin prior to venipuncture.
To minimize bacterial contamination, CBS uses a
diversion pouch for the first portion of the blood
donation that should capture the skin plug.
–	 Loss of sterility during component manufacturing or
handling.
Bacterial
Contamination in
RBC Unit
No picture available
at this time
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
REDCELLCOMPONENTS
Particulate matter
•	 Particulate matter, as opposed to foreign objects, can
be the result of blood collection and / or component
manufacturing processes. Composed of platelets, white
and red blood cells, and / or in some instances fibrin,
particulate matter may increase during storage of a
red cell unit. There are several categories of particulate
matter that may be found within in a red cell unit:
1.	 Clots and fibrin strands
–	 Clots and fibrin strands result from the
activation of the clotting processes and can be
a mixture of clotting proteins (including fibrin)
and platelets. Blood donations are collected and
processed in bags that contain anticoagulants
to inhibit the clotting processes. Blood
components containing clots and / or fibrin
strands should not be transfused.
–	 Clots may appear as small to large dark red or
purple masses that do not dissipate with gentle
manipulation in red cells.
10T05 021 JANUARY 2009
Clot in RBC unit
CANADIAN BLOOD SERVICES
REDCELLCOMPONENTS
11
2.	 Cellular aggregates
–	 Cellular aggregates may appear as white
and opaque masses that do not dissipate
with gentle manipulation. Blood components
containing cellular aggregates should not be
transfused.
3.	 White particulate matter (WPM)
–	 WPM is a non-cellular material and is a normal
constituent of blood. The WPM may dissipate
with a change in temperature.
–	 WPM is a lipid-rich material that appears white
in color and variable in shape, from flattened
specks to a greasy film. Generally there are low
numbers of WPM per red cell unit.
–	 The presence of WPM is acceptable for
transfusion.
4.	 Cold agglutinins form large red blood cell masses
that do not dissipate with gentle manipulation.
Blood components containing cold agglutinin
masses should not be transfused.
T05 021 JANUARY 2009
White
Particulate Matter
in RBC unit
T05 021 JANUARY 2009CANADIAN BLOOD SERVICES 12
REDCELLCOMPONENTS
White Particulate
Matter in RBC unit
CANADIAN BLOOD SERVICES
PLATELETCOMPONENTS
Platelet Units
There are three current methods of platelet
production: Pooled Platelets from BC
production, Random Donor Platelet units
from PRP production methods, and Apheresis
Platelets (AP).
Because platelet units contain cells and
plasma, they are opaque and vary in color
from beige to yellow. Residual red cells in
platelet units may confer a salmon / pink or
marked red colouring.
13
Platelet
Components
Typical Platelet (platelet pool from
4 donors using the buffy coat method)
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLATELETCOMPONENTS
14
Typical Platelet
(prepared by Apheresis)
Typical Platelet (prepared
using the PRP method)
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLATELETCOMPONENTS
15
Appearance of Platelets Units
There are several conditions that may change the
appearance of platelet units:
Red cell contamination
Red Cell Contamination in Pooled
Platelet Unit (platelets prepared
using the Buffy Coat method)
RBC contamination = 2.15 mL RBC.
•	 Visual appearance
–	 The degree of red discoloration reflects the amount
of red cell contamination and this varies from a
light pink / salmon color tinge to a marked red
discoloration.
•	 Red cell contamination occurs during production
and results from ineffective separation of red cells
and platelets. Currently there are no standards of
acceptability of red cell contamination for platelet units.
However, the AABB standards recommend compatability
testing when an apheresis platelet contains more than
2 ml of red cells. (ref AABB standard 24th
ed 5.14.5)
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLATELETCOMPONENTS
16
Red Cell Contamination in Platelets
(platelets prepared using the PRP method)
RBC contamination = 0.50 mL RBC
Lipemia
•	 Visual appearance
–	 Lipemia may result in a ‘milky’
white appearance.
•	 Lipemia is the presence of lipid
particles in the blood.
	 The presence of lipemia is acceptable for transfusion.
When excessive lipemia interferes with testing all
components are discarded at Canadian Blood Services.
•	 Causes of lipemia in a platelet unit are donor related and
may be related to:
–	 Fatty meals before blood donation
–	 Chronic conditions such as hypercholesterolemia
Icterus
•	 Visual appearance
–	 Bright yellow to brown.
•	 Icterus, describes the yellow discoloration due to high
bilirubin content in blood.
	 The presence of icterus is acceptable for transfusion.
Refer to
plasma
components for
photographs
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLATELETCOMPONENTS
17
When excessive bilirubin interferes with testing all
components are discarded at Canadian Blood Services.
•	 Causes of icterus in a platelet unit from eligible donors
may be related to:
–	 Inherited liver disorders (e.g. Gilbert’s Syndrome)
–	 Gallstones
Bacterial contamination
•	 Visual appearance - There are usually
no visible changes to the component,
but occasionally it may be possible to
detect the following:
–	 The presence of bacteria may
produce gas resulting in excessive
and unusual air bubbles.
–	 The presence of bacteria may activate clotting
resulting in clots and fibrin strands.
–	 Increased opacity
–	 Grey discoloration
•	 Bacterial contamination is the presence of bacteria in the
blood. Blood should be free of bacteria. Blood donations
are collected and then processed in a closed system to
maintain aseptic conditions. Canadian Blood Services
routinely tests platelets derived from whole blood or
aphereses for bacterial contamination.
Bacterial
contamination in
Platelet unit
No picture available
at this time
	 Bacterially contaminated blood components are not
acceptable for transfusion.
•	 Bacterial contamination may be related to the donor or
subsequent manufacturing processes.
–	 Donor with asymptomatic bacteremia (i.e. bacteria in
blood)
–	 Inadequate cleansing of skin prior to venipuncture.
To minimize bacterial contamination, CBS uses a
diversion pouch for the first portion of the blood
donation that should capture the skin plug.
–	 Loss of sterility during component manufacturing or
handling.
Particulate matter
•	 Visual appearance
–	 Clots may appear as white and opaque masses that do
not dissipate with gentle manipulation.
•	 Particulate matter, as opposed to foreign objects, can be the
result of blood collection and / or component manufacturing
processes. There are several categories of particulate
matter that may be found within in a platelet unit:
1.	 Clots and fibrin strands
–	 Clots and fibrin strands result from the activation
of the clotting processes and can be a mixture
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLATELETCOMPONENTS
18
of clotting proteins, platelets and fibrin. Blood
donations are collected and processed in bags
that contain anticoagulants to inhibit the clotting
processes. Blood components containing clots
and fibrin strands should not be transfused.
2.	 Cellular aggregates
–	 Cellular aggregates may appear as white and
opaque masses that do not dissipate with gentle
manipulation. Blood components containing
cellular aggregates should not be transfused.
Particulate Matter in Platelet Unit
(platelets prepared using the PRP method
Discoloration
•	 The term ‘discoloration’ refers to a variety of donor factors that
alter the plasma portion of platelet units and these can range
from metabolic conditions to medications or large doses of
vitamins taken by donors. Discoloration from contamination
with red cells or bacteria, can also be causes.
•	 Causes of discoloration, and their resulting alterations of plasma
color, include:
–	 Contamination
1.	 Red cell – see section 1, Platelet Components.
2.	 Bacterial – see section 4, Platelet Components.
Bacterially contaminated blood components are not
acceptable for transfusion.
–	 bright yellow to greenish brown – Icterus. Acceptable for
transfusion.
–	 light green – Oral contraceptive pill. Acceptable for
transfusion.
–	 bright orange – Vitamin A and large quantities of carrots.
Acceptable for transfusion.
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLASMACOMPONENTS
Plasma
Components
Plasma Units
Currently there are four plasma
components produced: Plasma, Frozen
Plasma, Fresh Frozen Plasma, and
Cryosupernatant Plasma.
19
Typical
Apheresis
Fresh
Frozen
Plasma
T05 021 JANUARY 2009
PLASMACOMPONENTS
CANADIAN BLOOD SERVICES 20
Examples of a Typical Plasma prepared from whole blood
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLASMACOMPONENTS
Appearance of Plasma Units
There are several conditions that may change the appearance
of plasma units:
Red cell contamination
•	 Red cell contamination occurs during production and
results from ineffective separation of red cells and plasma.
•	 Plasma unit
–	 The degree of red discoloration reflects the amount
of red cell contamination and this varies from a
light pink / salmon color tinge to a marked red
discoloration.
–	 Currently, there are no standards of acceptability for
red cell contamination of plasma units.
Lipemia
•	 Visual appearance
–	 Lipemia may result in a ‘milky’ white appearance.
•	 Lipemia is the presence of lipid particles in the blood.
	 The presence of lipemia is acceptable for transfusion.
Lipemic Plasma
21T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLASMACOMPONENTS
When excessive lipemia interferes with testing all
components are discarded at Canadian Blood Services.
•	 Causes of lipemia in a plasma unit are donor related and
may be related to:
–	 Fatty meals before blood donation
–	 Chronic conditions such as hypercholesterolemia
Icterus
•	 Visual appearance
–	 Bright yellow to brown.
•	 Icterus, describes the yellow discoloration due to high
bilirubin content in blood.
	 The presence of icterus in a blood component is acceptable
for transfusion. When excessive bilirubin interferes with
testing all components are discarded at Canadian Blood
Services.
•	 Causes of icterus in a plasma from eligible donors may be
related to:
–	 Inherited liver disorders (e.g. Gilbert’s Syndrome)
–	 Gallstones
Icteric Plasma
22T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLASMACOMPONENTS
Bacterial contamination
•	 Visual appearance - There are usually
no visible changes to the component,
but occasionally it may be possible to
detect the following:
–	 The presence of bacteria may
produce gas resulting in unusual
air bubbles.
–	 The presence of bacteria may activate clotting
resulting in clots and fibrin strands.
–	 Increased opacity.
•	 Bacterial contamination is the presence of bacteria
in the blood. Blood should be free of bacteria. Blood
donations are collected and then processed in a closed
system to maintain aseptic conditions.
	 Bacterially contaminated blood components are not
acceptable for transfusion.
•	 Bacterial contamination may be related to the donor or
subsequent manufacturing processes.
Bacterial
contamination in
Plasma unit
No picture available
at this time
–	 Donor with asymptomatic bacteremia (i.e. bacteria
in blood)
–	 Inadequate cleansing of skin prior to venipuncture.
To minimize bacterial contamination, CBS uses a
diversion pouch for the first portion of the blood
donation that should capture the skin plug.
–	 Loss of sterility during component manufacturing or
handling.
Particulate matter
•	 Visual appearance
–	 Particulate matter may appear as white and
opaque masses that do not dissipate with gentle
manipulation.
•	 Particulate matter, as opposed to foreign objects, can
be the result of blood collection and / or component
manufacturing processes. Composed of platelets, white
and red blood cells, and / or in some instances fibrin,
particulate matter may increase during storage of a
plasma unit. There are several categories of particulate
matter that may be found within in a plasma unit:
23T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLASMACOMPONENTS
1.	 Clots and fibrin strands
–	 Clots and fibrin strands result from the
activation of the clotting processes and can be
a mixture of clotting proteins (including fibrin)
and platelets. Blood donations are collected and
processed in bags that contain anticoagulants to
inhibit the clotting processes. Blood components
containing clots and fibrin strands should not be
transfused.
2.	 Cellular aggregates
–	 Cellular aggregates may appear as white and
opaque masses that do not dissipate with gentle
manipulation. Blood components containing
cellular aggregates should not be transfused.
3.	 White Particulate Matter (WPM)
–	 WPM may be seen in thawed plasma that has
been stored in the fridge. Components with
WPM are acceptable for transfusion.
Discoloration
•	 The term ‘discoloration’ refers to a variety of donor factors
that alter the plasma units and these can range from
metabolic conditions to medications or large doses of
vitamins taken by donors. Discoloration from contamination
with red cells and bacteria (see Appearance of Red Cell
Units), can also be causes.
•	 Causes of discoloration, and their resulting alterations of
plasma color, include:
–	 Contamination
1.	 Red cell – see section 1, Plasma Components.
2.	 Bacterial – see section 4, Plasma Components.
Bacterially contaminated blood components are not
acceptable for transfusion.
–	 bright yellow to greenish brown – Icterus. Acceptable
for transfusion.
–	 light green – Oral contraceptive pill. Acceptable for
transfusion.
–	 bright orange – Vitamin A and large quantities of carrots.
Acceptable for transfusion.
24T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
PLASMACOMPONENTS
Plasma with Green Colour (green colour is commonly
a result of donor taking oral contraceptive pill)
25T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
CRYOPRECIPITATECOMPONENTS
Cryoprecipitate
Components
Cryoprecipitate Units
Cryoprecipitate appears as a concentrated
precipitate at the bottom of a bag. It will
appear thick, opaque, whitish and paste-
like. Upon thawing, the cryoprecipitate
mass will dissolve and re-suspend in
the small amount of residual plasma and
appear as an even, thick, whitish liquid.
Appearance of Cryoprecipitate Units
There are several conditions that may
change the appearance of cryoprecipitate
units: The unusual conditions described in
the plasma components section may also
apply to cryoprecipitate components.
26
Examples of a Typical Cryoprecipitate
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES
REFERENCES
27
References
1.	 Visual Inspection Reference Guide, American National Red
Cross, American Red Cross Biomedical Services, 2006.
2.	 Standards for Blood Banks and Transfusion Services, 23rd
Edition. AABB, 2005.
3.	 FDA summary basis of approval for red blood cells frozen and
red blood cells deglycerolized (Reference number 86-0335).
Applicant-Department of the Navy, Navy Hospital, Bethesda,
MD, US License Number 635-10 1986.
4.	 Council of Europe. Guide to the preparation, use and quality
assurance of blood components, 9th
ed. Strasbourg, France:
Council of Europe Publishing, 2003.
5.	 Investigation of White Particulate Matter Found in Red Cell
Concentrates, Devine D, Canadian Blood Services, 2003.
6.	 Janatpour KA, Paglieroni TG, Crocker VL, et al. Visual
assessment of hemolysis in red blood cell units and segments
can be deceptive. Transfusion 2004:44:984-989.
7.	 Houseworth JL, Parks JA, Miguel EA, et al. Iatrogenic green
plasma. Transfusion 2005;45:1047.
8.	 CSA standard, Z 902-04 Blood and Blood components.
T05 021 JANUARY 2009
CANADIAN BLOOD SERVICES T05 021 JANUARY 2009 28
Acknowledgement
Canadian Blood Services extends thanks to those who contributed to the preparation of
this guide and to those who provided a peer review.
Dr. Jason Acker
Ryan Andress
Dr. Maggie Constantine
Shelley Doyle
Myriam Hurabielle
Craig Jenkins
Wanda Lefresne
Dr. Katherine Serrano
Susan Shimla
Dr. Tanya Petraszko
Janet Unrau
Fraser Health Authority, British Columbia
Vancouver Island Health Authority, British Columbia
Red Deer Regional Hospital, Alberta
Canadian Blood Services Staff, BC & Yukon
Canadian Blood Services Staff, Edmonton

More Related Content

What's hot

Haemoglobin quality control by maintaining levey jennings chart
Haemoglobin quality control by maintaining levey jennings chartHaemoglobin quality control by maintaining levey jennings chart
Haemoglobin quality control by maintaining levey jennings chartDr Rashmi Sood
 
Cross transfusion and compatibility
Cross transfusion and compatibilityCross transfusion and compatibility
Cross transfusion and compatibilityAhmad Qudah
 
Hematological stains
Hematological stainsHematological stains
Hematological stainsAkash Dhiman
 
collection of blood sample and preanalytical errors
collection of blood sample and preanalytical errorscollection of blood sample and preanalytical errors
collection of blood sample and preanalytical errorsUtkarsh Sharma
 
Gel card technology ppt nc
Gel card technology ppt ncGel card technology ppt nc
Gel card technology ppt ncNainshi Bhatt
 
OTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMSOTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMSFerdie Fatiga
 
Introduction to Apheresis (Dr. Nashwa Elsayed)
Introduction to Apheresis (Dr. Nashwa Elsayed)Introduction to Apheresis (Dr. Nashwa Elsayed)
Introduction to Apheresis (Dr. Nashwa Elsayed)Nashwa Elsayed
 
Apheresis 092909 Hames
Apheresis 092909 HamesApheresis 092909 Hames
Apheresis 092909 HamesTejas Desai
 
Anticoagulants and blood preservatives
Anticoagulants and blood preservativesAnticoagulants and blood preservatives
Anticoagulants and blood preservativesAmita Praveen
 
Platelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx finalPlatelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx finalAnupam Singh
 
Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)
Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)
Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)Nashwa Elsayed
 
Donor selection ppt
Donor selection pptDonor selection ppt
Donor selection pptdas nelaturi
 
‫ Preanalytical errors in hematolog
‫ Preanalytical errors in hematolog‫ Preanalytical errors in hematolog
‫ Preanalytical errors in hematologMEEQAT HOSPITAL
 
quality control in clinical pathology
quality control in clinical pathologyquality control in clinical pathology
quality control in clinical pathologyIshaque Vadakkethil
 
Rh factor and typing
Rh factor and typingRh factor and typing
Rh factor and typingSyeda Maryam
 
Body fluid analysis
Body fluid analysisBody fluid analysis
Body fluid analysisNiraj Gupta
 
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASESLABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASESSadd Alias
 

What's hot (20)

Haemoglobin quality control by maintaining levey jennings chart
Haemoglobin quality control by maintaining levey jennings chartHaemoglobin quality control by maintaining levey jennings chart
Haemoglobin quality control by maintaining levey jennings chart
 
quality control in blood banking
quality control in blood bankingquality control in blood banking
quality control in blood banking
 
Cross transfusion and compatibility
Cross transfusion and compatibilityCross transfusion and compatibility
Cross transfusion and compatibility
 
Hematological stains
Hematological stainsHematological stains
Hematological stains
 
collection of blood sample and preanalytical errors
collection of blood sample and preanalytical errorscollection of blood sample and preanalytical errors
collection of blood sample and preanalytical errors
 
Gel card technology ppt nc
Gel card technology ppt ncGel card technology ppt nc
Gel card technology ppt nc
 
OTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMSOTHER BLOOD GROUP SYSTEMS
OTHER BLOOD GROUP SYSTEMS
 
Introduction to Apheresis (Dr. Nashwa Elsayed)
Introduction to Apheresis (Dr. Nashwa Elsayed)Introduction to Apheresis (Dr. Nashwa Elsayed)
Introduction to Apheresis (Dr. Nashwa Elsayed)
 
Apheresis 092909 Hames
Apheresis 092909 HamesApheresis 092909 Hames
Apheresis 092909 Hames
 
Anticoagulants and blood preservatives
Anticoagulants and blood preservativesAnticoagulants and blood preservatives
Anticoagulants and blood preservatives
 
Cell block
Cell blockCell block
Cell block
 
Platelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx finalPlatelet function tests.pptx 2.pptx final
Platelet function tests.pptx 2.pptx final
 
Blood component preparation
Blood component preparationBlood component preparation
Blood component preparation
 
Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)
Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)
Performance Indicators in Blood Transfusion (Dr. Nashwa Elsayed)
 
Donor selection ppt
Donor selection pptDonor selection ppt
Donor selection ppt
 
‫ Preanalytical errors in hematolog
‫ Preanalytical errors in hematolog‫ Preanalytical errors in hematolog
‫ Preanalytical errors in hematolog
 
quality control in clinical pathology
quality control in clinical pathologyquality control in clinical pathology
quality control in clinical pathology
 
Rh factor and typing
Rh factor and typingRh factor and typing
Rh factor and typing
 
Body fluid analysis
Body fluid analysisBody fluid analysis
Body fluid analysis
 
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASESLABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
 

Viewers also liked

Laboratory diagnosis of_infectious_diseases
Laboratory diagnosis of_infectious_diseasesLaboratory diagnosis of_infectious_diseases
Laboratory diagnosis of_infectious_diseasesShilpa k
 
Tietotekniikka sukututkimuksen apuna
Tietotekniikka sukututkimuksen apunaTietotekniikka sukututkimuksen apuna
Tietotekniikka sukututkimuksen apunaJuhana Mykrä
 
ATK-opastajan valmennuskoulutuksen esittely
ATK-opastajan valmennuskoulutuksen esittelyATK-opastajan valmennuskoulutuksen esittely
ATK-opastajan valmennuskoulutuksen esittelyJuhana Mykrä
 
Strandénien kantatilat
Strandénien kantatilatStrandénien kantatilat
Strandénien kantatilatAdam40h
 
Pärjäävätkö koposet maailmalla
Pärjäävätkö koposet maailmallaPärjäävätkö koposet maailmalla
Pärjäävätkö koposet maailmallapkoponen
 
Melin bonjour sos (partie 1.2)
Melin bonjour   sos (partie 1.2)Melin bonjour   sos (partie 1.2)
Melin bonjour sos (partie 1.2)odeckmyn
 
Summer Training presentation
Summer Training presentationSummer Training presentation
Summer Training presentationMukul kashiwal
 
JEMS Aluminium Profile
JEMS Aluminium ProfileJEMS Aluminium Profile
JEMS Aluminium Profilechetan potdar
 
Sylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeri
Sylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeriSylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeri
Sylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeriIra Vihreälehto
 
Geneettinen sukututkimus Vesilahden seudulla
Geneettinen sukututkimus Vesilahden seudullaGeneettinen sukututkimus Vesilahden seudulla
Geneettinen sukututkimus Vesilahden seudullaMarja Pirttivaara
 
Suomi DNA projektin Luovutetun Karjalan isälinjoja
Suomi DNA projektin Luovutetun Karjalan isälinjojaSuomi DNA projektin Luovutetun Karjalan isälinjoja
Suomi DNA projektin Luovutetun Karjalan isälinjojaMarja Pirttivaara
 
Role of infection control in patient safety [compatibility mode]
Role of infection control in patient safety [compatibility mode]Role of infection control in patient safety [compatibility mode]
Role of infection control in patient safety [compatibility mode]drnahla
 
EXTRACTION OF DNA FROM BLOOD kit method
EXTRACTION OF DNA FROM BLOOD  kit method EXTRACTION OF DNA FROM BLOOD  kit method
EXTRACTION OF DNA FROM BLOOD kit method Smawi GH
 
Diagnosis of infectious diseases by dr.g.v.mali
Diagnosis of infectious diseases  by dr.g.v.maliDiagnosis of infectious diseases  by dr.g.v.mali
Diagnosis of infectious diseases by dr.g.v.maliDr. Gajanan Mali
 
Effective design and management of LEV systems
Effective design and management of LEV systemsEffective design and management of LEV systems
Effective design and management of LEV systemsMike Slater
 
catheter related blood stream infections-complete material
catheter related blood stream infections-complete materialcatheter related blood stream infections-complete material
catheter related blood stream infections-complete materialRahul Arya
 
VISUAL INSPECTION pt 2
VISUAL INSPECTION   pt 2VISUAL INSPECTION   pt 2
VISUAL INSPECTION pt 2Mogekwu Chinye
 

Viewers also liked (20)

Laboratory diagnosis of_infectious_diseases
Laboratory diagnosis of_infectious_diseasesLaboratory diagnosis of_infectious_diseases
Laboratory diagnosis of_infectious_diseases
 
Ppt
PptPpt
Ppt
 
Tietotekniikka sukututkimuksen apuna
Tietotekniikka sukututkimuksen apunaTietotekniikka sukututkimuksen apuna
Tietotekniikka sukututkimuksen apuna
 
ATK-opastajan valmennuskoulutuksen esittely
ATK-opastajan valmennuskoulutuksen esittelyATK-opastajan valmennuskoulutuksen esittely
ATK-opastajan valmennuskoulutuksen esittely
 
Strandénien kantatilat
Strandénien kantatilatStrandénien kantatilat
Strandénien kantatilat
 
Pärjäävätkö koposet maailmalla
Pärjäävätkö koposet maailmallaPärjäävätkö koposet maailmalla
Pärjäävätkö koposet maailmalla
 
Melin bonjour sos (partie 1.2)
Melin bonjour   sos (partie 1.2)Melin bonjour   sos (partie 1.2)
Melin bonjour sos (partie 1.2)
 
Summer Training presentation
Summer Training presentationSummer Training presentation
Summer Training presentation
 
JEMS Aluminium Profile
JEMS Aluminium ProfileJEMS Aluminium Profile
JEMS Aluminium Profile
 
Sylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeri
Sylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeriSylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeri
Sylkeä putkeen -DNA-testit, haploryhmät ja isänisän mysteeri
 
Sukututkimusta- ja suomalaisten_esihistoriaa_dna-tutkimuksen_avulla
Sukututkimusta- ja suomalaisten_esihistoriaa_dna-tutkimuksen_avullaSukututkimusta- ja suomalaisten_esihistoriaa_dna-tutkimuksen_avulla
Sukututkimusta- ja suomalaisten_esihistoriaa_dna-tutkimuksen_avulla
 
Geneettinen sukututkimus Vesilahden seudulla
Geneettinen sukututkimus Vesilahden seudullaGeneettinen sukututkimus Vesilahden seudulla
Geneettinen sukututkimus Vesilahden seudulla
 
Kuulutko sukuuni 2015
Kuulutko sukuuni 2015Kuulutko sukuuni 2015
Kuulutko sukuuni 2015
 
Suomi DNA projektin Luovutetun Karjalan isälinjoja
Suomi DNA projektin Luovutetun Karjalan isälinjojaSuomi DNA projektin Luovutetun Karjalan isälinjoja
Suomi DNA projektin Luovutetun Karjalan isälinjoja
 
Role of infection control in patient safety [compatibility mode]
Role of infection control in patient safety [compatibility mode]Role of infection control in patient safety [compatibility mode]
Role of infection control in patient safety [compatibility mode]
 
EXTRACTION OF DNA FROM BLOOD kit method
EXTRACTION OF DNA FROM BLOOD  kit method EXTRACTION OF DNA FROM BLOOD  kit method
EXTRACTION OF DNA FROM BLOOD kit method
 
Diagnosis of infectious diseases by dr.g.v.mali
Diagnosis of infectious diseases  by dr.g.v.maliDiagnosis of infectious diseases  by dr.g.v.mali
Diagnosis of infectious diseases by dr.g.v.mali
 
Effective design and management of LEV systems
Effective design and management of LEV systemsEffective design and management of LEV systems
Effective design and management of LEV systems
 
catheter related blood stream infections-complete material
catheter related blood stream infections-complete materialcatheter related blood stream infections-complete material
catheter related blood stream infections-complete material
 
VISUAL INSPECTION pt 2
VISUAL INSPECTION   pt 2VISUAL INSPECTION   pt 2
VISUAL INSPECTION pt 2
 

Similar to Visual inspection guide for blood compopnents

Blood and its applied aspect related to oral health
Blood and its applied aspect related to oral healthBlood and its applied aspect related to oral health
Blood and its applied aspect related to oral healthRiddhikaKochar1
 
Peripheral blood smear examination
Peripheral blood smear examinationPeripheral blood smear examination
Peripheral blood smear examinationBahoran Singh Rajput
 
Blood and blood related products
Blood and blood related productsBlood and blood related products
Blood and blood related productsAnuroop U P
 
bloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdfbloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdfjnrkwesi
 
Pharmaceutics MTI Lecture nine of vaccines and blood
Pharmaceutics MTI Lecture nine of vaccines and bloodPharmaceutics MTI Lecture nine of vaccines and blood
Pharmaceutics MTI Lecture nine of vaccines and bloodahmedsharaf738754
 
1. BLOOD Part 1-1.pptx
1. BLOOD Part 1-1.pptx1. BLOOD Part 1-1.pptx
1. BLOOD Part 1-1.pptxPoNNw
 
Blood transfusion, Nutrition and water & electrolyte balance
Blood transfusion, Nutrition and water & electrolyte balanceBlood transfusion, Nutrition and water & electrolyte balance
Blood transfusion, Nutrition and water & electrolyte balanceRamesh Parajuli
 
Microscopic examination of urine
Microscopic examination of urineMicroscopic examination of urine
Microscopic examination of urineglobalsoin
 

Similar to Visual inspection guide for blood compopnents (20)

Blood and its applied aspect related to oral health
Blood and its applied aspect related to oral healthBlood and its applied aspect related to oral health
Blood and its applied aspect related to oral health
 
Peripheral blood smear examination
Peripheral blood smear examinationPeripheral blood smear examination
Peripheral blood smear examination
 
Blood and blood related products
Blood and blood related productsBlood and blood related products
Blood and blood related products
 
Lab blood gm unit 7
Lab blood gm unit 7Lab blood gm unit 7
Lab blood gm unit 7
 
05 blood liquid connective tissue
05 blood liquid connective tissue05 blood liquid connective tissue
05 blood liquid connective tissue
 
bloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdfbloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdf
 
Pharmaceutics MTI Lecture nine of vaccines and blood
Pharmaceutics MTI Lecture nine of vaccines and bloodPharmaceutics MTI Lecture nine of vaccines and blood
Pharmaceutics MTI Lecture nine of vaccines and blood
 
BLOOD TRANSFUSION.pptx
BLOOD TRANSFUSION.pptxBLOOD TRANSFUSION.pptx
BLOOD TRANSFUSION.pptx
 
Blood samples
Blood samplesBlood samples
Blood samples
 
RBC
RBCRBC
RBC
 
blood products .pdf
blood products .pdfblood products .pdf
blood products .pdf
 
Blood count
Blood countBlood count
Blood count
 
Blood smear
Blood smearBlood smear
Blood smear
 
1. BLOOD Part 1-1.pptx
1. BLOOD Part 1-1.pptx1. BLOOD Part 1-1.pptx
1. BLOOD Part 1-1.pptx
 
1a hematology slides
1a hematology slides1a hematology slides
1a hematology slides
 
Blood transfusion, Nutrition and water & electrolyte balance
Blood transfusion, Nutrition and water & electrolyte balanceBlood transfusion, Nutrition and water & electrolyte balance
Blood transfusion, Nutrition and water & electrolyte balance
 
Peripheral smear
Peripheral smear Peripheral smear
Peripheral smear
 
Microscopic examination of urine
Microscopic examination of urineMicroscopic examination of urine
Microscopic examination of urine
 
1. BLOOD Part 1.pptx
1. BLOOD Part 1.pptx1. BLOOD Part 1.pptx
1. BLOOD Part 1.pptx
 
Coagulation.pptx
Coagulation.pptxCoagulation.pptx
Coagulation.pptx
 

Recently uploaded

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...Catherine Liao
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsLanceCatedral
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Catherine Liao
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryDr Simran Deepak Vangani
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxdrwaque
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Catherine Liao
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexClive Bates
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...Catherine Liao
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxDr. Rabia Inam Gandapore
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentabdeli bhadarva
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Catherine Liao
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341Sherrylee83
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdfKs doctor
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...kevinkariuki227
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...KavyasriPuttamreddy
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxRohit chaurpagar
 

Recently uploaded (20)

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 

Visual inspection guide for blood compopnents

  • 2. CANADIAN BLOOD SERVICES T05 021 JANUARY 2009 i Table of Contents Introduction 1 How to Use 3 Quick Reference Guide Table 1 - Summary of Visual Appearance 4 Table 2 - Summary of Acceptability Criteria 5 Red Cell Components 6 Platelet Components 12 Plasma Components 18 Cryoprecipitate Components 25 References 26 Acknowledgement 27 ISBN 978-1-926581-14-9 © 2009, Canadian Blood Services
  • 3. T05 021 JANUARY 2009CANADIAN BLOOD SERVICES 1 INTRODUCTION Typical Platelet (platelet pool from 4 donors using the buffy coat method) Introduction Whole blood donations are collected into a closed bag system that permits aseptic separation into red cells, platelets, plasma and cryoprecipitate. Currently, there are three whole blood processing systems used by the Canadian Blood Services: Buffy Coat (BC) method, Platelet Rich Plasma (PRP) method and Whole Blood (WB) filtration. Platelet and plasma components are also collected by apheresis. Blood components manufactured by Canadian Blood Services are done so under strict manufacturing protocols.
  • 4. CANADIAN BLOOD SERVICES INTRODUCTION 2 This guide has been produced for use by both Canadian Blood Services and hospital personnel. The acceptability of a blood component for release from Canadian Blood Services is determined by Canadian Blood Services protocols and procedures. The acceptability of a blood component for transfusion will be determined by local hospital policy and procedures under the direction of the Transfusion Services Medical Director (ref CSA-Z902-04 4.3.6.1). Typical Plasma prepared from whole blood T05 021 JANUARY 2009
  • 5. T05 021 JANUARY 2009CANADIAN BLOOD SERVICES HOWTOUSE This guide is divided into four sections covering the four blood components. Each section begins with a brief explanation of the component, a description of the variations in appearance for that component and criteria for acceptability. Inspection of the blood products should take place in a well-lit area. Coloured products have been photographed against a white background, whereas light-coloured (white) products have been photographed against a dark background to obtain a better viewing contrast. Visual Assessments Guides printed by the Canadian Blood Services are laminated to increase their durability; however the quality of the photographs may decrease over time. How to Use This Visual Assessment Guide Prolonged exposure to sunlight or fluorescent lighting may cause fading and to maintain the quality of the photographs, please keep the guide closed when not in use. This guide is available on www.transfusionmedicine.ca and if it is printed locally or viewed on-line the pictures may not be color-true. Table 1 is a quick guide for conditions that affect the visual appearance of components. Not all conditions affect all components. Table 2 is a summary of the acceptability criteria. Note: Storage containers may differ in appearance depending on bag vendor. Labels may or may not appear on the back of products and label formats and locations may be different. 3
  • 6. T05 021 JANUARY 2009CANADIAN BLOOD SERVICES QUICKREFERENCEGUIDE Affected Component Condition Red cells Platelets Plasma Cryoprecipitate Hemolysis • Loss of intact red cells results in lower hematocrit and a brighter cherry red color. • Free hemoglobin imparts a light pink tinge to a dark red almost purple color to the supernatant. • Occurs as part of normal aging process n/a • Red cells present in plasma will hemolyze during the freeze/thaw process and will impart a pink to red tinge depending on number of red cells involved • Red cells present in plasma will hemolyze during the freeze/thaw process and will impart a pink to red tinge depending on number of red cells involved Red cell contamination n/a • Varies from a light pink / salmon color tinge to a marked red discoloration • Varies from a light pink / salmon color tinge to a marked red discoloration • Varies from a light pink / salmon color tinge to a marked red discoloration Lipemia • A lighter shade of red and an increased opacity of the unit similar to a ‘strawberry milkshake’ • Increased opacity • ‘Milky’ white appearance • Increased opacity • ‘Milky’ white appearance • Increased opacity • ‘Milky’ white appearance Icterus n/a • Bright yellow to brown • Bright yellow to brown • Bright yellow to brown Bacterial contamination • A dark purple to black discoloration in red cells • Excessive and unusual air bubbles • Clots and fibrin strands • Increased opacity • When assosiated with hemolysis, a pink to red discoloration may be seen in supernatant. • Excessive and unusual air bubbles • Clots and fibrin strands • Increased opacity • Grey discoloration • Excessive and unusual air bubbles • Clots and fibrin strands • Increased opacity • Excessive and unusual air bubbles • Clots and fibrin strands • Increased opacity Particulate matter • Clots appear as small to large dark red or purple masses that do not dissipate with gentle manipulation in red cells. • Cellular aggregates appear as white and opaque masses that do not dissipate with gentle manipulation. • White particulate matter varies from flattened specks to a greasy film and may dissipate with a change in temperature • Cold agglutinins form large red blood cell masses that do not dissipate with gentle manipulation. • Clots and fibrin strands result from the activation of the clotting process and may appear as white/opaque masses or whitish thread like strands that do not dissipate with gentle manipulation • Cellular aggregates may appear as white and opaque masses that do not dissipate with gentle manipulation. • Particulate matter may vary considerably in size. • Clots and fibrin strands result from the activation of the clotting process and may appears as white/opaque masses or whitish thread like strands that do not dissipate with gentle manipulation • Cellular aggregates may appear as white and opaque masses that do not dissipate with gentle manipulation. • Particulate matter may vary considerably in size. • Clots and fibrin strands result from the activation of the clotting process and may appears as white/opaque masses or whitish thread like strands that do not dissipate with gentle manipulation • Cellular aggregates may appear as white and opaque masses that do not dissipate with gentle manipulation. • Particulate matter may vary considerably in size. Discoloration • See hemolysis, lipemia, bacterial contamination • Pink, red, bright orange / yellow, bright green, or brown • Pink, red, bright orange / yellow, bright green, or brown • Pink, red, bright orange / yellow, bright green, or brown Quick Reference Guide Table 1. Visual appearance of blood components n/a=Not applicable 4
  • 7. T05 021 JANUARY 2009CANADIAN BLOOD SERVICES 5 QUICKREFERENCEGUIDE Affected Component Condition Red cells Platelets Plasma Cryoprecipitate Hemolysis • Some degree of hemolysis is acceptable and expected. The CSA standard will define acceptable levels of hemolysis as < 0.8% at expiry. n/a • Some degree of hemolysis is possible depending on the number of red cells in the plasma. • Some degree of hemolysis is possible depending on the number of red cells in the plasma. Red cell contamination n/a • Currently there are no standards of acceptability of red cell contamination for platelet units. However, the AABB standards recommend compatibility testing when an apheresis platelet contains more than 2ml of red cells (ref AABB standard 24th ed 5.14.5). • Currently, there are no standards of acceptability for red cell contamination of plasma units. • Currently, there are no standards of acceptability for red cell contamination of plasma units. Lipemia • Blood components with lipemia are acceptable for transfusion. • Blood components with lipemia are acceptable for transfusion. • Blood components with lipemia are acceptable for transfusion. • Blood components with lipemia are acceptable for transfusion. Icterus • Blood components with icterus are acceptable for transfusion. • Blood components with icterus are acceptable for transfusion. • Blood components with icterus are acceptable for transfusion. • Blood components with icterus are acceptable for transfusion. Bacterial contamination • Bacterially contaminated blood components are not acceptable for transfusion • Canadian Blood Services routinely tests platelets derived from whole blood or apheresis for bacterial contamination. Bacterially contaminated blood components are not acceptable for transfusion. • Bacterially contaminated blood components are not acceptable for transfusion • Bacterially contaminated blood components are not acceptable for transfusion Particulate matter • Clots and fibrin - Blood components containing clots and / or fibrin strands should not be transfused. • Cellular aggregates - Blood components containing cellular aggregates should not be transfused. • White Particulate Matter (WPM). Blood components containing WPM are acceptable for transfusion. WPM may dissipate with a change in temperature. • Cold agglutinins - Blood components containing cold agglutinin masses should not be transfused. • Clots and fibrin Strands - Blood components containing clots and/or fibrin strands should not be transfused. • Cellular aggregates- Blood components containing cellular aggregates should not be transfused. • Clots and fibrin - Blood components containing clots and / or fibrin strands should not be transfused. • Cellular Aggregates - Blood components containing cellular aggregates should not be transfused. • White Particulate Matter (WPM) - WPM may be seen in thawed plasma that has been stored in the fridge. Blood components containing WPM are acceptable for transfusion • Clots and fibrin - Blood components containing clots and / or fibrin strands should not be transfused. • Cellular Aggregates - Blood components containing cellular aggregates should not be transfused. • White Particulate Matter (WPM) - WPM may be seen in thawed plasma that has been stored in the fridge. Blood components containing WPM are acceptable for transfusion Discoloration • See hemolysis, lipemia, bacterial contamination • Discoloration due to icterus (yellow), oral contraceptives (green), vitamin A or large quantities of carrots (orange) are all acceptable for transfusion. • Discoloration due to icterus (yellow), oral contraceptives (green), vitamin A or large quantities of carrots (orange) are all acceptable for transfusion. • Discoloration due to icterus (yellow), oral contraceptives (green), vitamin A or large quantities of carrots (orange) are all acceptable for transfusion. Quick Reference Guide Table 2. Acceptability criteria of blood components n/a=Not applicable
  • 8. CANADIAN BLOOD SERVICES REDCELLCOMPONENTS Typical Red Blood Cells prepared from whole blood Red Cell Components Red Cell Units Red cell units are an even suspension of red cells in a small amount of residual plasma and additive solution. The visual appearance of segments should not be used to assess a red cell unit as they may not reflect the content of the bag.6 Units should be allowed to settle to permit an assessment of the supernatant. There is a normal variation in the shade of red seen in red cell units that may reflect a difference in the hematocrit of the donor (i.e. a higher hematocrit will result in a darker red). 6T05 021 JANUARY 2009
  • 9. CANADIAN BLOOD SERVICES REDCELLCOMPONENTS Appearance of Red Cell Units There are several conditions that may change the appearance of the red cell unit: Hemolysis • Visual appearance – Of particular note, hemolysis caused by bacterial contamination may result in a dark purple to black discoloration (see ‘Bacterial Contamination’). – Free hemoglobin within the supernatant of red cells will cause a discoloration that will vary from a light pink tinge to a dark red almost purple color, depending on the extent of hemolysis (i.e. a higher degree of hemolysis will result in a darker discoloration). • Hemolysis is the break down of red cells and the subsequent release of hemoglobin, the pigmented protein in red cells. Hemolysis of stored red cells is a normal process and increases with storage times. Some degree of hemolysis is acceptable and expected. The CSA standard will define acceptable levels of hemolysis as < 0.8% at expiry. 7 • Visual assessment of supernatant color is the only non-destructive means to estimate hemolysis in a red cell unit. It is very subjective and it is difficult to define a “cut-off” color for determining a unit’s acceptability. The color of the supernatant varies according to the volume of the supernatant and the hematocrit and hemoglobin levels in the red cell unit. The presence of red cells in the supernatant may be mistaken for hemolysis. If hemolysis is suspected, it may be worthwhile to allow the unit to settle for 24 hours or more to minimize red cell contamination of the supernatant prior to inspection for hemolysis. • There are numerous causes of hemolysis. A few examples related to the manufacturing process and subsequent handling of red cell units are: – Temperature extremes – Excessive centrifugation – Tubing stripping – Tubing heat sealers – Sheer force during manufacturing eg. kinked tubing, improperly broken cannula – Bacterial contamination – Mishandling – Incompatible solutions T05 021 JANUARY 2009
  • 10. CANADIAN BLOOD SERVICES REDCELLCOMPONENTS 8 Supernatant of RBC Percent Hemolysis = 0.11 % Photographs were taken after allowing the RBC to settle for 4 days to permit an evident visualization of the supernatant. This assessment may be performed earlier or later. Supernatant of RBC Percent Hemolysis = 0.36 % Supernatant of RBC showing higher levels of hemolysis Percent Hemolysis = 1.14 % T05 021 JANUARY 2009 The CSA standard will define acceptable levels of hemolysis as < 0.8% at expiry.
  • 11. CANADIAN BLOOD SERVICES REDCELLCOMPONENTS Lipemia • Visual appearance – The appearance of a lipemic red cell unit has been compared to a ‘strawberry milkshake’. • Lipemia is the presence of lipid particles in the blood. The presence of lipemia is acceptable for transfusion. When excessive lipemia interferes with testing all components are discarded at Canadian Blood Services. • Causes of lipemia in a red cell unit are donor related and may be related to: – Fatty meals before blood donation – Chronic conditions such as hypercholesterolemia Bacterial contamination • Visual appearance – There are usually no visible changes to the component, but occasionally it may be possible to detect the following: – Growing bacteria within a red cell unit may consume the oxygen and cause a dark purple to black discoloration in red cells. – The presence of bacteria may produce gas resulting in excessive and unusual air bubbles. Lipemic RBC Unit No picture available at this time 9 – The presence of bacteria may activate clotting resulting in clots and fibrin strands. – Increased opacity – Because bacterial contamination can cause hemolysis, a pink to red discoloration may be seen in the supernatant. • Bacterial contamination is the presence of bacteria in the blood. Blood should be free of bacteria. Blood donations are collected and then processed in a closed system to maintain aseptic conditions. Bacterially contaminated blood components are not acceptable for transfusion. • Bacterial contamination may be related to the donor or subsequent manufacturing processes. – Donor with asymptomatic bacteremia (i.e. bacteria in blood) – Inadequate cleansing of skin prior to venipuncture. To minimize bacterial contamination, CBS uses a diversion pouch for the first portion of the blood donation that should capture the skin plug. – Loss of sterility during component manufacturing or handling. Bacterial Contamination in RBC Unit No picture available at this time T05 021 JANUARY 2009
  • 12. CANADIAN BLOOD SERVICES REDCELLCOMPONENTS Particulate matter • Particulate matter, as opposed to foreign objects, can be the result of blood collection and / or component manufacturing processes. Composed of platelets, white and red blood cells, and / or in some instances fibrin, particulate matter may increase during storage of a red cell unit. There are several categories of particulate matter that may be found within in a red cell unit: 1. Clots and fibrin strands – Clots and fibrin strands result from the activation of the clotting processes and can be a mixture of clotting proteins (including fibrin) and platelets. Blood donations are collected and processed in bags that contain anticoagulants to inhibit the clotting processes. Blood components containing clots and / or fibrin strands should not be transfused. – Clots may appear as small to large dark red or purple masses that do not dissipate with gentle manipulation in red cells. 10T05 021 JANUARY 2009 Clot in RBC unit
  • 13. CANADIAN BLOOD SERVICES REDCELLCOMPONENTS 11 2. Cellular aggregates – Cellular aggregates may appear as white and opaque masses that do not dissipate with gentle manipulation. Blood components containing cellular aggregates should not be transfused. 3. White particulate matter (WPM) – WPM is a non-cellular material and is a normal constituent of blood. The WPM may dissipate with a change in temperature. – WPM is a lipid-rich material that appears white in color and variable in shape, from flattened specks to a greasy film. Generally there are low numbers of WPM per red cell unit. – The presence of WPM is acceptable for transfusion. 4. Cold agglutinins form large red blood cell masses that do not dissipate with gentle manipulation. Blood components containing cold agglutinin masses should not be transfused. T05 021 JANUARY 2009 White Particulate Matter in RBC unit
  • 14. T05 021 JANUARY 2009CANADIAN BLOOD SERVICES 12 REDCELLCOMPONENTS White Particulate Matter in RBC unit
  • 15. CANADIAN BLOOD SERVICES PLATELETCOMPONENTS Platelet Units There are three current methods of platelet production: Pooled Platelets from BC production, Random Donor Platelet units from PRP production methods, and Apheresis Platelets (AP). Because platelet units contain cells and plasma, they are opaque and vary in color from beige to yellow. Residual red cells in platelet units may confer a salmon / pink or marked red colouring. 13 Platelet Components Typical Platelet (platelet pool from 4 donors using the buffy coat method) T05 021 JANUARY 2009
  • 16. CANADIAN BLOOD SERVICES PLATELETCOMPONENTS 14 Typical Platelet (prepared by Apheresis) Typical Platelet (prepared using the PRP method) T05 021 JANUARY 2009
  • 17. CANADIAN BLOOD SERVICES PLATELETCOMPONENTS 15 Appearance of Platelets Units There are several conditions that may change the appearance of platelet units: Red cell contamination Red Cell Contamination in Pooled Platelet Unit (platelets prepared using the Buffy Coat method) RBC contamination = 2.15 mL RBC. • Visual appearance – The degree of red discoloration reflects the amount of red cell contamination and this varies from a light pink / salmon color tinge to a marked red discoloration. • Red cell contamination occurs during production and results from ineffective separation of red cells and platelets. Currently there are no standards of acceptability of red cell contamination for platelet units. However, the AABB standards recommend compatability testing when an apheresis platelet contains more than 2 ml of red cells. (ref AABB standard 24th ed 5.14.5) T05 021 JANUARY 2009
  • 18. CANADIAN BLOOD SERVICES PLATELETCOMPONENTS 16 Red Cell Contamination in Platelets (platelets prepared using the PRP method) RBC contamination = 0.50 mL RBC Lipemia • Visual appearance – Lipemia may result in a ‘milky’ white appearance. • Lipemia is the presence of lipid particles in the blood. The presence of lipemia is acceptable for transfusion. When excessive lipemia interferes with testing all components are discarded at Canadian Blood Services. • Causes of lipemia in a platelet unit are donor related and may be related to: – Fatty meals before blood donation – Chronic conditions such as hypercholesterolemia Icterus • Visual appearance – Bright yellow to brown. • Icterus, describes the yellow discoloration due to high bilirubin content in blood. The presence of icterus is acceptable for transfusion. Refer to plasma components for photographs T05 021 JANUARY 2009
  • 19. CANADIAN BLOOD SERVICES PLATELETCOMPONENTS 17 When excessive bilirubin interferes with testing all components are discarded at Canadian Blood Services. • Causes of icterus in a platelet unit from eligible donors may be related to: – Inherited liver disorders (e.g. Gilbert’s Syndrome) – Gallstones Bacterial contamination • Visual appearance - There are usually no visible changes to the component, but occasionally it may be possible to detect the following: – The presence of bacteria may produce gas resulting in excessive and unusual air bubbles. – The presence of bacteria may activate clotting resulting in clots and fibrin strands. – Increased opacity – Grey discoloration • Bacterial contamination is the presence of bacteria in the blood. Blood should be free of bacteria. Blood donations are collected and then processed in a closed system to maintain aseptic conditions. Canadian Blood Services routinely tests platelets derived from whole blood or aphereses for bacterial contamination. Bacterial contamination in Platelet unit No picture available at this time Bacterially contaminated blood components are not acceptable for transfusion. • Bacterial contamination may be related to the donor or subsequent manufacturing processes. – Donor with asymptomatic bacteremia (i.e. bacteria in blood) – Inadequate cleansing of skin prior to venipuncture. To minimize bacterial contamination, CBS uses a diversion pouch for the first portion of the blood donation that should capture the skin plug. – Loss of sterility during component manufacturing or handling. Particulate matter • Visual appearance – Clots may appear as white and opaque masses that do not dissipate with gentle manipulation. • Particulate matter, as opposed to foreign objects, can be the result of blood collection and / or component manufacturing processes. There are several categories of particulate matter that may be found within in a platelet unit: 1. Clots and fibrin strands – Clots and fibrin strands result from the activation of the clotting processes and can be a mixture T05 021 JANUARY 2009
  • 20. CANADIAN BLOOD SERVICES PLATELETCOMPONENTS 18 of clotting proteins, platelets and fibrin. Blood donations are collected and processed in bags that contain anticoagulants to inhibit the clotting processes. Blood components containing clots and fibrin strands should not be transfused. 2. Cellular aggregates – Cellular aggregates may appear as white and opaque masses that do not dissipate with gentle manipulation. Blood components containing cellular aggregates should not be transfused. Particulate Matter in Platelet Unit (platelets prepared using the PRP method Discoloration • The term ‘discoloration’ refers to a variety of donor factors that alter the plasma portion of platelet units and these can range from metabolic conditions to medications or large doses of vitamins taken by donors. Discoloration from contamination with red cells or bacteria, can also be causes. • Causes of discoloration, and their resulting alterations of plasma color, include: – Contamination 1. Red cell – see section 1, Platelet Components. 2. Bacterial – see section 4, Platelet Components. Bacterially contaminated blood components are not acceptable for transfusion. – bright yellow to greenish brown – Icterus. Acceptable for transfusion. – light green – Oral contraceptive pill. Acceptable for transfusion. – bright orange – Vitamin A and large quantities of carrots. Acceptable for transfusion. T05 021 JANUARY 2009
  • 21. CANADIAN BLOOD SERVICES PLASMACOMPONENTS Plasma Components Plasma Units Currently there are four plasma components produced: Plasma, Frozen Plasma, Fresh Frozen Plasma, and Cryosupernatant Plasma. 19 Typical Apheresis Fresh Frozen Plasma T05 021 JANUARY 2009
  • 22. PLASMACOMPONENTS CANADIAN BLOOD SERVICES 20 Examples of a Typical Plasma prepared from whole blood T05 021 JANUARY 2009
  • 23. CANADIAN BLOOD SERVICES PLASMACOMPONENTS Appearance of Plasma Units There are several conditions that may change the appearance of plasma units: Red cell contamination • Red cell contamination occurs during production and results from ineffective separation of red cells and plasma. • Plasma unit – The degree of red discoloration reflects the amount of red cell contamination and this varies from a light pink / salmon color tinge to a marked red discoloration. – Currently, there are no standards of acceptability for red cell contamination of plasma units. Lipemia • Visual appearance – Lipemia may result in a ‘milky’ white appearance. • Lipemia is the presence of lipid particles in the blood. The presence of lipemia is acceptable for transfusion. Lipemic Plasma 21T05 021 JANUARY 2009
  • 24. CANADIAN BLOOD SERVICES PLASMACOMPONENTS When excessive lipemia interferes with testing all components are discarded at Canadian Blood Services. • Causes of lipemia in a plasma unit are donor related and may be related to: – Fatty meals before blood donation – Chronic conditions such as hypercholesterolemia Icterus • Visual appearance – Bright yellow to brown. • Icterus, describes the yellow discoloration due to high bilirubin content in blood. The presence of icterus in a blood component is acceptable for transfusion. When excessive bilirubin interferes with testing all components are discarded at Canadian Blood Services. • Causes of icterus in a plasma from eligible donors may be related to: – Inherited liver disorders (e.g. Gilbert’s Syndrome) – Gallstones Icteric Plasma 22T05 021 JANUARY 2009
  • 25. CANADIAN BLOOD SERVICES PLASMACOMPONENTS Bacterial contamination • Visual appearance - There are usually no visible changes to the component, but occasionally it may be possible to detect the following: – The presence of bacteria may produce gas resulting in unusual air bubbles. – The presence of bacteria may activate clotting resulting in clots and fibrin strands. – Increased opacity. • Bacterial contamination is the presence of bacteria in the blood. Blood should be free of bacteria. Blood donations are collected and then processed in a closed system to maintain aseptic conditions. Bacterially contaminated blood components are not acceptable for transfusion. • Bacterial contamination may be related to the donor or subsequent manufacturing processes. Bacterial contamination in Plasma unit No picture available at this time – Donor with asymptomatic bacteremia (i.e. bacteria in blood) – Inadequate cleansing of skin prior to venipuncture. To minimize bacterial contamination, CBS uses a diversion pouch for the first portion of the blood donation that should capture the skin plug. – Loss of sterility during component manufacturing or handling. Particulate matter • Visual appearance – Particulate matter may appear as white and opaque masses that do not dissipate with gentle manipulation. • Particulate matter, as opposed to foreign objects, can be the result of blood collection and / or component manufacturing processes. Composed of platelets, white and red blood cells, and / or in some instances fibrin, particulate matter may increase during storage of a plasma unit. There are several categories of particulate matter that may be found within in a plasma unit: 23T05 021 JANUARY 2009
  • 26. CANADIAN BLOOD SERVICES PLASMACOMPONENTS 1. Clots and fibrin strands – Clots and fibrin strands result from the activation of the clotting processes and can be a mixture of clotting proteins (including fibrin) and platelets. Blood donations are collected and processed in bags that contain anticoagulants to inhibit the clotting processes. Blood components containing clots and fibrin strands should not be transfused. 2. Cellular aggregates – Cellular aggregates may appear as white and opaque masses that do not dissipate with gentle manipulation. Blood components containing cellular aggregates should not be transfused. 3. White Particulate Matter (WPM) – WPM may be seen in thawed plasma that has been stored in the fridge. Components with WPM are acceptable for transfusion. Discoloration • The term ‘discoloration’ refers to a variety of donor factors that alter the plasma units and these can range from metabolic conditions to medications or large doses of vitamins taken by donors. Discoloration from contamination with red cells and bacteria (see Appearance of Red Cell Units), can also be causes. • Causes of discoloration, and their resulting alterations of plasma color, include: – Contamination 1. Red cell – see section 1, Plasma Components. 2. Bacterial – see section 4, Plasma Components. Bacterially contaminated blood components are not acceptable for transfusion. – bright yellow to greenish brown – Icterus. Acceptable for transfusion. – light green – Oral contraceptive pill. Acceptable for transfusion. – bright orange – Vitamin A and large quantities of carrots. Acceptable for transfusion. 24T05 021 JANUARY 2009
  • 27. CANADIAN BLOOD SERVICES PLASMACOMPONENTS Plasma with Green Colour (green colour is commonly a result of donor taking oral contraceptive pill) 25T05 021 JANUARY 2009
  • 28. CANADIAN BLOOD SERVICES CRYOPRECIPITATECOMPONENTS Cryoprecipitate Components Cryoprecipitate Units Cryoprecipitate appears as a concentrated precipitate at the bottom of a bag. It will appear thick, opaque, whitish and paste- like. Upon thawing, the cryoprecipitate mass will dissolve and re-suspend in the small amount of residual plasma and appear as an even, thick, whitish liquid. Appearance of Cryoprecipitate Units There are several conditions that may change the appearance of cryoprecipitate units: The unusual conditions described in the plasma components section may also apply to cryoprecipitate components. 26 Examples of a Typical Cryoprecipitate T05 021 JANUARY 2009
  • 29. CANADIAN BLOOD SERVICES REFERENCES 27 References 1. Visual Inspection Reference Guide, American National Red Cross, American Red Cross Biomedical Services, 2006. 2. Standards for Blood Banks and Transfusion Services, 23rd Edition. AABB, 2005. 3. FDA summary basis of approval for red blood cells frozen and red blood cells deglycerolized (Reference number 86-0335). Applicant-Department of the Navy, Navy Hospital, Bethesda, MD, US License Number 635-10 1986. 4. Council of Europe. Guide to the preparation, use and quality assurance of blood components, 9th ed. Strasbourg, France: Council of Europe Publishing, 2003. 5. Investigation of White Particulate Matter Found in Red Cell Concentrates, Devine D, Canadian Blood Services, 2003. 6. Janatpour KA, Paglieroni TG, Crocker VL, et al. Visual assessment of hemolysis in red blood cell units and segments can be deceptive. Transfusion 2004:44:984-989. 7. Houseworth JL, Parks JA, Miguel EA, et al. Iatrogenic green plasma. Transfusion 2005;45:1047. 8. CSA standard, Z 902-04 Blood and Blood components. T05 021 JANUARY 2009
  • 30. CANADIAN BLOOD SERVICES T05 021 JANUARY 2009 28 Acknowledgement Canadian Blood Services extends thanks to those who contributed to the preparation of this guide and to those who provided a peer review. Dr. Jason Acker Ryan Andress Dr. Maggie Constantine Shelley Doyle Myriam Hurabielle Craig Jenkins Wanda Lefresne Dr. Katherine Serrano Susan Shimla Dr. Tanya Petraszko Janet Unrau Fraser Health Authority, British Columbia Vancouver Island Health Authority, British Columbia Red Deer Regional Hospital, Alberta Canadian Blood Services Staff, BC & Yukon Canadian Blood Services Staff, Edmonton